How to Avoid disability patent retrieval - Eureka

Novel synthetic triterpenoids and methods of use in the treatment and prevention of multiple scleroris

InactiveUS20090060873A1Improving glomerular filtration rateImproving creatinine clearanceBiocideSalicyclic acid active ingredientsDiseaseBipolar mood disorder

The present invention overcomes limitations of the prior art by providing new compounds and methods for the treatment of conditions, such as neurodegenerative diseases (e.g., multiple sclerosis), psychiatric disorders (e.g., psychosis, bipolar disorder, depression, neuropathic pain), conditions involving CNS-mediated chronic pain, spinal cord injuries, and other diseases or injuries.

Novel synthetic triterpenoids and methods of use in the treatment and prevention of multiple scleroris

View all

Owner:TRUSTEES OF DARTMOUTH COLLEGE THE +1

Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring

ActiveUS7915402B2Suppresses demyelinationSuppresses transectionNervous disorderAntipyreticPerylene derivativesPharmaceutical Substances

This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula:wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.

Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring

View all

Owner:REATA PHARMA INC

Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives

ActiveUS7943778B2Suppresses demyelinationSuppresses transectionAntibacterial agentsSenses disorderAntioxidantMedicinal chemistry

This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula:wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.

Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives

View all

Owner:REATA PHARMA INC

Antioxidant inflammation modulators: novel derivatives of oleanolic acid

ActiveUS20100048911A1Suppresses demyelinationSuppresses transectionBiocideNervous disorderAntioxidantCancer

Disclosed herein are novel oleanolic acid derivatives. Methods of preparing these compounds are also disclosed. The oleanolic acid derivatives of this invention may be used for the treatment and prevention of many diseases, including cancer, neurological disorders, inflammation, and pathologies involving oxidative stress.

Antioxidant inflammation modulators: novel derivatives of oleanolic acid

View all

Owner:REATA PHARM INC

Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17

ActiveUS8124799B2Suppresses demyelinationSuppresses transectionSenses disorderNervous disorderAntioxidantInflammation

This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula:wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.

Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17

View all

Owner:REATA PHARM HLDG LLC

Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17

ActiveUS20100048892A1Improving glomerular filtration rateImproving creatinine clearanceSenses disorderNervous disorderAntioxidantInflammation

This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula:

wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.

View all

Owner:REATA PHARM HLDG LLC

Compounds including an Anti-inflammatory pharmacore and methods of use

ActiveUS20100048887A1Suppresses demyelinationSuppresses transectionSenses disorderNervous disorderDrugAnti-inflammatory

This invention provides novel compounds comprising the following anti-inflammatory pharmacore:wherein X, R1 and R2 are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.

Compounds including an Anti-inflammatory pharmacore and methods of use

View all

Owner:REATA PHARMA INC

Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring

ActiveUS20100056777A1Suppresses demyelinationSuppresses transectionNervous disorderAntipyreticAntioxidantMedicinal chemistry

This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula:wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.

View all

Owner:REATA PHARMA INC

Antioxidant inflammation modulators: c-17 homologated oleanolic acid derivatives

ActiveUS20100041904A1Suppresses demyelinationSuppresses transectionAntibacterial agentsSenses disorderAntioxidantMedicinal chemistry

This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula:wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.

View all

Owner:REATA PHARMA INC

Antioxidant inflammation modulators: novel derivatives of oleanolic acid

InactiveUS20120238767A1Suppresses demyelinationSuppresses transectionNervous disorderSteroidsDiseaseOxidative stress

Disclosed herein are novel oleanolic acid derivatives. Methods of preparing these compounds are also disclosed. The oleanolic acid derivatives of this invention may be used for the treatment and prevention of many diseases, including cancer, neurological disorders, inflammation, and pathologies involving oxidative stress.

View all

Owner:REATA PHARMA INC

Antioxidant inflammation modulators: novel derivatives of oleanolic acid

ActiveUS8071632B2Suppresses demyelinationSuppresses transectionBiocideNervous disorderDiseaseMedicine

Disclosed herein are novel oleanolic acid derivatives. Methods of preparing these compounds are also disclosed. The oleanolic acid derivatives of this invention may be used for the treatment and prevention of many diseases, including cancer, neurological disorders, inflammation, and pathologies involving oxidative stress.

View all

Owner:REATA PHARMA INC

Monocyclic cyanoenones and methods of use thereof

ActiveUS20110196007A1Improving glomerular filtration rateImproving creatinine clearanceBiocideSenses disorderMedicineNeuro-degenerative disease

The present invention features monocyclic cyanoenone compositions and methods for using the same in the treatment of diseases such as cancer, inflammatory diseases and neurodegenerative diseases.

Monocyclic cyanoenones and methods of use thereof

View all

Owner:TRUSTEES OF DARTMOUTH COLLEGE THE

Dehydroandrosterone analogs including an anti-inflammatory pharmacore and methods of use

ActiveUS8258329B2Suppresses demyelinationSuppresses transectionSenses disorderNervous disorderStereochemistryAnti-inflammatory analgesics

This invention provides novel compounds comprising the following anti-inflammatory pharmacore:wherein X, R1 and R2 are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.

Dehydroandrosterone analogs including an anti-inflammatory pharmacore and methods of use

View all

Owner:REATA PHARMA INC

Monocyclic cyanoenones and methods of use thereof

ActiveUS8314137B2Suppresses demyelinationSuppresses transectionBiocideSenses disorderMedicineDisease cause

The present invention features monocyclic cyanoenone compositions and methods for using the same in the treatment of diseases such as cancer, inflammatory diseases and neurodegenerative diseases.

View all

Owner:TRUSTEES OF DARTMOUTH COLLEGE THE

Traditional Chinese medicine formulation paris polyphylla direct-oral decoction piece for preventing and treating tumors

ActiveCN103393896AStrong complexionRelieve painAntineoplastic agentsPlant ingredientsFreeze-dryingEngineering

The invention belongs to the technical field of traditional Chinese medicines and relates to a processing method of a traditional Chinese medicine formulation paris polyphylla direct-oral decoction piece, namely a paris polyphylla freeze-dried powder wall-breaking oral decoction piece, with the effects of clearing away heat and toxic materials and preventing and treating tumors. A finished product is obtained through the following steps of: pretreating; freeze-drying; drying for the second time; crushing; granulating, and the like. The prepared product ensures that the paris polyphylla freeze-dried powder wall-breaking oral decoction piece disclosed by the invention has the advantages of light weight, portability, flexibility in preparation and fast usage, can be used for farthest preserving the drug effect components of an original drug and reducing the property of a crude drug, enhances the quality and drug effect of the paris polyphylla decoction piece, reduces the waste and consumption of paris polyphylla wild resources and improves the utilization ratio of the effective components of paris polyphylla.

Traditional Chinese medicine formulation paris polyphylla direct-oral decoction piece for preventing and treating tumors

View all

Owner:磐安县道地磐药中药研究所

Taping tape

InactiveUS20090104402A1Alleviate muscle painAvoid disabilityAdhesive dressingsAbsorbent padsEngineeringMechanical engineering

A taping tape includes: a base material 12 having elasticity; an adhesive layer attached to one side of the base material 12; and plural slits 14 that are formed along one direction on an inner side of the base material 12 and are arranged parallel to each other. Both side edge portions 12a and 12b of the base material 12 in the vicinities of end portions of the slits 14 are formed obliquely to each other towards a longitudinal direction center of the base material 12 from the vicinities of the end portions of the slits 14 to base material end portions 12c and 12d positioned on extensions of the slits 14. The end portions of the slits 14 curve towards the center of the base material 12 along the side edge portions 12a and 12b.

View all

Owner:ESAKI MEDICAL INSTR

Taping tape

InactiveUS7951443B2Alleviate muscle painAvoid disabilityAdhesive dressingsAbsorbent padsEngineeringMechanical engineering

A taping tape includes: a base material 12 having elasticity; an adhesive layer attached to one side of the base material 12; and plural slits 14 that are formed along one direction on an inner side of the base material 12 and are arranged parallel to each other. Both side edge portions 12a and 12b of the base material 12 in the vicinities of end portions of the slits 14 are formed obliquely to each other towards a longitudinal direction center of the base material 12 from the vicinities of the end portions of the slits 14 to base material end portions 12c and 12d positioned on extensions of the slits 14. The end portions of the slits 14 curve towards the center of the base material 12 along the side edge portions 12a and 12b.

View all

Owner:ESAKI MEDICAL INSTR

Transparent substrate with multilayer Anti-glare coating

ActiveUS20170031063A1Reduce reflectivityAvoid disabilityAntiglare equipmentCoatingsRefractive indexDielectric layer

A transparent substrate with a multilayer anti-glare coating includes a transparent substrate; a first coating layer formed on the transparent substrate and being formed of a first dielectric layer having a refractive index of n1; a second coating layer formed on the first coating layer and being formed of a metal oxide layer having a refractive index of n2; a third coating layer formed on the second coating layer and being formed of a second dielectric layer having a refractive index of n3; and a fourth coating layer formed on the third coating layer and being formed of a third dielectric layer having a refractive index of n4. The refractive indexes of the coating layers satisfy: n1=n3>n2>n4.

Transparent substrate with multilayer Anti-glare coating

View all

Owner:HYUNDAI MOTOR CO LTD +1

Beer pong gaming system and automatic scoring system for beer pong game

InactiveUS10226676B2Low costDrawback can be solvedIndoor gamesNear-field in RFIDEngineeringAutomatic testing

The present disclosure provides a beer pong game system comprising a game table, a plurality of game cups, and at least one game ball, the game table being equipped with an RFID reader and a plurality of RFID antennas, the RFID antennas one-to-one corresponding to to-be-detected positions of the game cups; an electronic tag being affixed at a bottom of a game cup; an electronic tag being inlaid inside the game ball; the beer pong game system being characterized in comprising a make detecting unit that identifies, at predetermined to-be-detected positions of game balls, the electronic tags of the game balls by scanning corresponding RFID antennas, thereby determining a make result and prompting a first landing mode; and a cup-removal scoring unit that identifies, at to-be-detected positions of all game cups, electronic tags of the game cups by scanning all RFID antennas, thereby inferring a second landing mode and correspondingly scoring.

Beer pong gaming system and automatic scoring system for beer pong game

View all

Owner:YIP KA HING STEVEN

Serpinf2-Binding Molecules and Method of Use Thereof

ActiveUS20140220034A1Reduced activityReduce concentrationNervous disorderDigestive systemMedicineApoptosis

Compositions and methods of using SerpinF2-binding molecules for preventing and/or reducing organ damage, functional disability or mortality in a patient at risk due to the activity of SerpinF2 and/or plasminogen activators on tissue injury. Also provided are compositions and methods of using SerpinF2-binding molecules for inhibiting hemorrhage, edema, and apoptosis. Methods for the preparation of medicaments for such methods of treatment and prevention are provided.

Serpinf2-Binding Molecules and Method of Use Thereof

View all

Owner:TRANSLATIONAL SCI

Network device, communication method, program, and recording medium

ActiveUS9906421B2Avoid disabilityData switching networksTime segmentRecording media

According to the present invention, a network device includes a plurality of ports which are connected to a LAN; a communication controller; and a communication shutoff release unit. The communication controller includes: a linkup detection unit, a loop detection frame sending out unit that sends out the loop detection frame from a linkup detected port, which is a port for which the linkup is detected, after a predetermined period from a time point when the linkup is detected by the linkup detection unit to the local area network, and a loop detection frame detection unit that detects the loop detection frame if the loop detection frame is received on the each port. The communication shutoff release unit releases the shutoff of the communication on the linkup detected port only if the loop detection frame is not detected by the loop detection frame detection unit.

Network device, communication method, program, and recording medium

View all

Owner:ALLIED TELESIS

Vehicle communication system, battery management device, circuit board, battery, and communication specification switching method

ActiveUS20190165433A1DisabilityAvoid disabilityBatteries circuit arrangementsCells structural combinationCommunications systemElectrical battery

A vehicle communication system includes: a control device 10B provided in a vehicle; and a management device 50 that is provided in a battery 20 mounted on the vehicle while communicably connected to the control device 10B. One of the control device 10B and the management device 50 discriminates a communication specification of the other and switches the communication specification. In this configuration, consistency of the communication specification is attained between the control device 10B of the vehicle and the battery 20, so that disability of communication between the control device 10B and the battery 20 can be prevented.

Vehicle communication system, battery management device, circuit board, battery, and communication specification switching method

View all

Owner:GS YUASA INT LTD

Intelligent integrated circuit (IC) card water meter outer box

InactiveCN103116946AAvoid disabilityImprove accuracyApparatus for hiring articlesEngineeringIntegrated circuit

The invention discloses an intelligent integrated circuit (IC) card water meter outer box which comprises an upper cover (1) and a box body (2). An IC card water meter body is located inside the box body (2). The upper cover (1) and the IC card water meter body are arranged in a separated mode. An observation opening (3) is formed in the front portion of the upper cover (1). A fixed type card swiping area (4) is arranged on the surface of the rear portion of the upper cover (1). A card groove (5) is formed in the card swiping area (4). The card groove (5) corresponds to the size of an IC card. The intelligent IC card water meter outer box not only can protect the water meter, but also can accurately read out data and keep the cleaning of an intelligent water meter.

View all

Owner:孙建东

Clinical condition evaluation new system for predicting one-year joint destruction progress of rheumatoid arthritis patient

PendingCN110136833AProgression of joint destruction is reduced or blockedDestruction progression is reduced or blockedHealth-index calculationIntensive treatmentLower risk

The invention discloses a clinical condition evaluation new system for predicting a one-year joint destruction progress of a rheumatoid arthritis patient. According to the invention, a new index whichcan be used for predicting the one-year joint destruction progress of the rheumatoid arthritis patient is researched, namely a limb muscle index (ASMI), and the clinical condition evaluation new system for predicting the one-year joint destruction progress of the rheumatoid arthritis patient is established based on the limb muscle index. The system can accurately screen the high-risk patient, themiddle-risk patient and the low-risk patient in the one-year joint destruction progress earlier than prior art for nine months to one year, and different treatment plans are utilized for the high-risk patient, the middle-risk patient and the low-risk patient, thereby realizing intensive treatment of the high-risk patient and the middle-risk patient earlier for nine months to one year, guiding clinical medicine taking for more effectively reducing or blocking the joint destruction progress of the rheumatoid arthritis patient, preventing disability, and realizing important meaning and high value in treatment controlling and monitoring of rheumatoid arthritis.

Clinical condition evaluation new system for predicting one-year joint destruction progress of rheumatoid arthritis patient

View all

Owner:SUN YAT SEN MEMORIAL HOSPITAL SUN YAT SEN UNIV

One group of primers for detecting FVIII/FIX gene mutations of patient with hemophilia and application of one group of primers

ActiveCN108315406AExact classificationThe classification method is reliableMicrobiological testing/measurementDNA/RNA fragmentationClassification methodsHemophilia patient

The invention discloses one group of primers for detecting FVIII/FIX gene mutations of a patient with hemophilia and application of one group of primers. The primers are 8 pairs of F9 primers, 39 pairs of 22 inversion 3 F8 primers and 1 inversion 4 F8 primers, can be used for etiological classification of hemophilia, can be applied to treatment of a non-factor drug to the hemophilia according to etiological classification of the hemophilia and can enable the patient with the hemophilia to change from severe type to a moderate type and a mild type. By adopting the primers, an acquired getter FVIII/FIX:C can be returned mormality; and further verified that the hemophilia etiological classification method provided by the invention is definite and reliable, opens up a new thought and a new wayof preventing hemophilia bleeding and avoiding disability and has an important significance of guiding prenatal and postnatal care and blocking inheritance.

One group of primers for detecting FVIII/FIX gene mutations of patient with hemophilia and application of one group of primers

View all

Owner:陕西医大血友病研究院

Safe and efficient duck catching method in duck shed

ActiveCN110352871AReduce cleaning labor intensityEasy to adjust the lengthAvicultureCage cultureEngineering

The invention relates to the technical field of meat duck cage culture, in particular to a safe and efficient duck catching method in a duck shed. According to the safe and efficient duck catching method for the duck shed, duck catching operation is realized through nondestructive cage door opening hooks, a duck-catching slow-down platform mechanism, a duck catching trolley for movement and a duckpushing plate, so that the duck catching time is greatly shortened; and meat ducks in duck cages on the left and right sides simultaneously slide down along a sliding plate of the duck-catching slow-down platform mechanism at the middle of the duck shed, and the time from opening the cage door to completing duck catching and closing the cage door is about 30-40s, so that the duck catching processis greatly shortened, and manpower and material resources are saved.

Safe and efficient duck catching method in duck shed

View all

Owner:新泰市天信农牧发展有限公司

System for predicting one-year joint damage progress of rheumatoid arthritis patient

ActiveCN112599243AImprove forecast accuracyEasy to operateHealth-index calculationMedical automated diagnosisIntensive treatmentJoint damage

The invention discloses a system for predicting one-year joint damage progress of a rheumatoid arthritis patient. The system comprises an immunopathology marker score determination module, an optimized synovial membrane cellular immunology score calculation module, a joint damage progress risk comparison module and a risk result display module. According to the system, the cell immunological scoreof the synovial membrane with the optimized evaluation index constructed by immunopathology markers related to the synovial membrane is used as the prediction index for the first time to predict thecondition of one-year joint damage progress of rheumatoid arthritis patients, and high-risk patients with the joint damage progress can be accurately screened out one year in advance; high-risk patients can be subjected to intensive treatment one year ahead of time, so that the joint damage progress of the patients can be effectively reduced or blocked, and the method has important significance and clinical value for accurate treatment of RA and reduction of disability rate.

System for predicting one-year joint damage progress of rheumatoid arthritis patient

View all

Owner:SUN YAT SEN MEMORIAL HOSPITAL SUN YAT SEN UNIV

Serpinf2-Binding Molecules and Method of Use Thereof

PendingUS20220298261A1Avoid deathAvoid disabilityNervous disorderDigestive systemZymogenPLG - Plasminogen

Compositions and methods of using SerpinF2-binding molecules for preventing and / or reducing organ damage, functional disability or mortality in a patient at risk due to the activity of SerpinF2 and / or plasminogen activators on tissue injury. Also provided are compositions and methods of using SerpinF2-binding molecules for inhibiting hemorrhage, edema, and apoptosis. Methods for the preparation of medicaments for such methods of treatment and prevention are provided.

View all

Owner:TRANSLATIONAL SCI

Vehicle communication system, battery management device, circuit board, battery, and communication specification switching method

ActiveUS10637107B2DisabilityAvoid disabilityBatteries circuit arrangementsCells structural combinationCommunications systemIn vehicle

A vehicle communication system includes: a control device 10B provided in a vehicle; and a management device 50 that is provided in a battery 20 mounted on the vehicle while communicably connected to the control device 10B. One of the control device 10B and the management device 50 discriminates a communication specification of the other and switches the communication specification. In this configuration, consistency of the communication specification is attained between the control device 10B of the vehicle and the battery 20, so that disability of communication between the control device 10B and the battery 20 can be prevented.

View all

Owner:GS YUASA INT LTD

Ankle rehabilitation training apparatus for patients with gout

InactiveCN110916971AAvoid disabilityAvoid stayingChiropractic devicesEngineeringPhysical therapy

The invention belongs to the field of ankle rehabilitation training, and especially discloses ankle rehabilitation training apparatus for patients with gout. In order to solve the problem of unable meeting of needs of use caused by necessity of frequent manual rehabilitation training by accompanying personnel at present, the invention discloses a scheme as follows: the ankle rehabilitation training apparatus for the patients with gout comprises an apparatus body which adopts a hollow structure; a fixing groove is formed at a bottom end of an inner wall of the apparatus body; an iron block is provided inside the fixing groove in a movable way; a mounting base is connected with a top end of the iron block, and extends outside the fixing groove; the iron block is provided with a spring on oneside far away from the mounting base; one end of the spring, which is far away from the iron block, is arranged on an inner-wall bottom end of the fixing groove; a magnet is provided on one side of an inner wall of the fixing groove; and a movable plate is provided on the iron block on one side far away from the magnet. The ankle rehabilitation training apparatus for the patients with gout is rational in structure, and capable of realizing rehabilitation training of bare feet from multiple angles; and moreover, the ankle rehabilitation training apparatus is also capable of avoiding disabilityof the patients caused by non-flowing of the blood, thereby meeting the needs of use.

Ankle rehabilitation training apparatus for patients with gout

View all

Owner:赵田田

43results about How to "Avoid disability" patented technology

Novel synthetic triterpenoids and methods of use in the treatment and prevention of multiple scleroris

Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring

Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives

Antioxidant inflammation modulators: novel derivatives of oleanolic acid

Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17

Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17

Compounds including an Anti-inflammatory pharmacore and methods of use

Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring

Antioxidant inflammation modulators: c-17 homologated oleanolic acid derivatives

Antioxidant inflammation modulators: novel derivatives of oleanolic acid

Antioxidant inflammation modulators: novel derivatives of oleanolic acid

Monocyclic cyanoenones and methods of use thereof

Dehydroandrosterone analogs including an anti-inflammatory pharmacore and methods of use

Monocyclic cyanoenones and methods of use thereof

Traditional Chinese medicine formulation paris polyphylla direct-oral decoction piece for preventing and treating tumors

Taping tape

Taping tape

Transparent substrate with multilayer Anti-glare coating

Beer pong gaming system and automatic scoring system for beer pong game

Serpinf2-Binding Molecules and Method of Use Thereof

Network device, communication method, program, and recording medium

Vehicle communication system, battery management device, circuit board, battery, and communication specification switching method

Intelligent integrated circuit (IC) card water meter outer box

Clinical condition evaluation new system for predicting one-year joint destruction progress of rheumatoid arthritis patient

One group of primers for detecting FVIII/FIX gene mutations of patient with hemophilia and application of one group of primers

Safe and efficient duck catching method in duck shed

System for predicting one-year joint damage progress of rheumatoid arthritis patient

Serpinf2-Binding Molecules and Method of Use Thereof

Vehicle communication system, battery management device, circuit board, battery, and communication specification switching method

Ankle rehabilitation training apparatus for patients with gout

Popular searches